Analyst firms · Morgan Stanley · LEA
Morgan Stanley LEA price target and rating history
Lear Corporation (LEA) · Consumer Discretionary
Morgan Stanley rates Lear Corporation (LEA) Overweight with a $160 price target, as of its latest action on May 10, 2024. It has published 3 rating actions on LEA since December 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a LEA price target in the last 12 months, the median target is $165.
- Current rating
- Overweight
- Price target
- $160
- Median target, all firms
- $165
- Actions on LEA
- 3
Morgan Stanley price target on LEA
Every Morgan Stanley rating on LEA
- May 10, 2024
- Feb 28, 2022
- Dec 14, 2021
How other firms rate LEA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BNP Paribas Exane | Neutral | Aug 3, 2026 | |
| TD Cowen | Buy | $165 | May 26, 2026 |
| RBC Capital Markets | Sector Perform | $135 | Mar 12, 2026 |
| BofA Securities | Neutral | Mar 4, 2026 | |
| The Benchmark Company | Buy | $170 | Feb 19, 2026 |
Questions about Morgan Stanley and LEA
- What is Morgan Stanley's price target for LEA?
- Morgan Stanley's latest stated price target for Lear Corporation (LEA) is $160, from its action on May 10, 2024.
- What is Morgan Stanley's rating on LEA?
- Morgan Stanley rates LEA Overweight, a bullish rating, as of May 10, 2024.
- When did Morgan Stanley last change its view on LEA?
- On May 10, 2024, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $150 to $160.
- How does Morgan Stanley's LEA target compare with other analysts?
- Across 3 firms with a LEA price target in the last 12 months, the median target is $165.
More LEA rating histories
- BNP Paribas Exane4
- TD Cowen3
- RBC Capital Markets3
- BofA Securities5
- The Benchmark Company3
- Goldman Sachs3
- Barclays6
- Deutsche Bank4
- Wells Fargo8
All Morgan Stanley ratingsLEA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.